SCHEMBL1872014

SCHEMBL1872014

N#Cc1cc(S(=O)(=O)NC(=O)c2ccccc2Oc2cnc3[nH]ccc3c2)cnc1OCCC1CCOCC1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 19/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30314052 1.00 BCL2 (0.62) BCL2
SCHEMBL30313864 0.94 BCL2 (0.61) BCL2
SCHEMBL1874264 0.94 BCL2 (0.61) BCL2
SCHEMBL30313979 0.88 BCL2 (0.61) BCL2
SCHEMBL1876180 0.88 BCL2 (0.61) BCL2
SCHEMBL30314029 0.88 BCL2 (0.64) BCL2
SCHEMBL30314042 0.88 BCL2 (0.62) BCL2
SCHEMBL29796319 0.87 BCL2 (0.60) BCL2
SCHEMBL2724142 0.86 BCL2 (0.62) BCL2
SCHEMBL30313885 0.86 BCL2 (0.62) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138588-A9 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-05-05 — — WO claimed
Send feedback